
Abbott Diagnostics - Product Pipeline Analysis, 2022 Update
Description
Summary
Abbott Diagnostics (Abbott) a subsidiary of Abbott Laboratories, is a manufacturer of in vitro diagnostic systems and tests. The company offers various core laboratory products, molecular point of care products, transfusion medicine, professional services and diagnostics. Abbott products portfolio include laboratory systems for automation; molecular diagnostic systems, and point of care systems for blood analysis. The company products find application in therapeutic drug monitoring, measurement of antibodies and antigens, and screening and diagnosis of cancer. Abbott serves blood banks, hospitals, commercial laboratories, government agencies, patient care testing sites, and plasma protein therapeutic companies. The company markets its products through Abbott-owned distribution centers, public warehouses and third-party distributors. Abbott is headquartered in Lake Forest, Illinois, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
Abbott Diagnostics (Abbott) a subsidiary of Abbott Laboratories, is a manufacturer of in vitro diagnostic systems and tests. The company offers various core laboratory products, molecular point of care products, transfusion medicine, professional services and diagnostics. Abbott products portfolio include laboratory systems for automation; molecular diagnostic systems, and point of care systems for blood analysis. The company products find application in therapeutic drug monitoring, measurement of antibodies and antigens, and screening and diagnosis of cancer. Abbott serves blood banks, hospitals, commercial laboratories, government agencies, patient care testing sites, and plasma protein therapeutic companies. The company markets its products through Abbott-owned distribution centers, public warehouses and third-party distributors. Abbott is headquartered in Lake Forest, Illinois, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Abbott Diagnostics
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
334 Pages
- Abbott Diagnostics Company Overview
- Abbott Diagnostics Company Snapshot
- Abbott Diagnostics Pipeline Products and Ongoing Clinical Trials Overview
- Abbott Diagnostics – Pipeline Analysis Overview
- Abbott Diagnostics - Key Facts
- Abbott Diagnostics - Major Products and Services
- Abbott Diagnostics Pipeline Products by Development Stage
- Abbott Diagnostics Ongoing Clinical Trials by Trial Status
- Abbott Diagnostics Pipeline Products Overview
- 13q14.3 Companion Diagnostic Assay - Chronic Lymphocytic Leukemia
- ACTN4 Companion Diagnostic Assay - Lung Cancer
- AKT Companion Diagnostic Assay - Breast Cancer
- AKT Companion Diagnostic Assay - Colorectal Cancer
- AKT Companion Diagnostic Assay - Renal Cancer
- Alinity i AdviseDx SARS-CoV-2 IgM Assay
- Alinity i Assay - TBI
- ALK Companion Diagnostic Assay - Colorectal Cancer
- ALK Companion Diagnostic Assay - Lung Cancer
- AR Companion Diagnostic Assay - Breast Cancer
- AR Companion Diagnostic Assay - Prostate Cancer
- Architect AdviseDx SARS-Cov-2 IgM Assay
- Architect Assay - TBI
- ARCHITECT c16000 System - Ca 72.2 Assay
- ARCHITECT c4000 System - Ca 72.2 Assay
- ARCHITECT c4000 System - High Sensitive Troponin-I Assay
- ARCHITECT c4000 System - Kappa And Lamda Freelite Chains Assay
- ARCHITECT c4000 System - TRAb Assay
- ARCHITECT c8000 Integrated System - Galectin-3 Assay
- ARCHITECT c8000 System - Ca 72.2 Assay
- ARCHITECT c8000 System - High Sensitive Troponin-I Assay
- ARCHITECT c8000 System - Kappa And Lamda Freelite Chains Assay
- ARCHITECT c8000 System - TRAb Assay
- ARCHITECT ci16200 Integrated System - Ca 72.2 Assay
- ARCHITECT ci16200 Integrated System - Kappa And Lamda Freelite Chains Assay
- ARCHITECT ci16200 Integrated System - NT Pro BNP Assay
- ARCHITECT ci16200 Integrated System - TRAb Assay
- ARCHITECT ci4100 Integrated System - NT Pro BNP Assay
- ARCHITECT ci4100 Integrated System - TRAb Assay
- ARCHITECT ci8200 Integrated System - Ca 72.2 Assay
- ARCHITECT ci8200 Integrated System - Kappa And Lamda Freelite Chains Assay
- ARCHITECT ci8200 Integrated System - TRAb Assay
- ARCHITECT i1000SR - NT Pro BNP Assay
- ARCHITECT i2000SR Integrated System - NT Pro BNP Assay
- ATM 11q22.3 Companion Diagnostic Assay - Chronic Lymphocytic Leukemia
- AURKA Companion Diagnostic Assay - Bladder Cancer
- AURKA Companion Diagnostic Assay - Prostate Cancer
- AXL Companion Diagnostic Assay - Lung Cancer
- BCL2 Companion Diagnostic Assay - Leukemia
- BCL2 Companion Diagnostic Assay - Lymphoma
- BCL6 Companion Diagnostic Assay - Lymphoma
- BCR/ABL Companion Diagnostic Assay - Acute Lymphocytic Leukemia
- BCR/ABL Companion Diagnostic Assay - Acute Myeloid Leukemia
- Biomarker-Based Molecular Diagnostic Test - Prostate Cancer
- BRAF Companion Diagnostic Assay - Colorectal Cancer
- BRAF Companion Diagnostic Assay - Gastric Cancer
- BRAF Companion Diagnostic Assay - Glioblastoma
- BRAF Companion Diagnostic Assay - Lung Cancer
- BRAF Companion Diagnostic Assay - Melanoma
- BRAF Companion Diagnostic Assay - Ovarian Cancer
- BRCA1 Companion Diagnostic Assay - Ovarian Cancer
- BRCA2 Companion Diagnostic Assay - Ovarian Cancer
- c-MYC 8q24 Companion Diagnostic Assay - Multiple Myeloma
- CBFB Companion Diagnostic Assay - Acute Myeloid Leukemia
- CCND1 Companion Diagnostic Assay - Breast Cancer
- CCND1 Companion Diagnostic Assay - Lymphoma
- CCND1 Companion Diagnostic Assay - Melanoma
- CDK6 Companion Diagnostic Assay - Leukemia
- CDKN2C Companion Diagnostic Assay - Multiple Myeloma
- CEBPE Companion Diagnostic Assay - Myelodysplastic Syndrome
- CEP 9 Companion Diagnostic Assay - Multiple Myeloma
- Chromosome 12 Companion Diagnostic Assay - Chronic Lymphocytic Leukemia
- Chromosome 17 Companion Diagnostic Assay - Acute Lymphocytic Leukemia
- Chromosome 3 Companion Diagnostic Assay - Cervical Cancer
- Chromosome 4 Companion Diagnostic Assay - Acute Lymphocytic Leukemia
- Chromosome 7 Companion Diagnostic Assay - Acute Lymphocytic Leukemia
- Chromosome 7 Companion Diagnostic Assay - Acute Myeloid Leukemia
- Chromosome 8 Companion Diagnostic Assay - Acute Myeloid Leukemia
- Chromosome X Companion Diagnostic Assay - Cervical Cancer
- cKIT Companion Diagnostic Assay - Gastric Cancer
- cKIT Companion Diagnostic Assay - Melanoma
- CKS1B Companion Diagnostic Assay - Breast Cancer
- CKS1B Companion Diagnostic Assay - Multiple Myeloma
- CLL FISH Probe Kit - Ibrutinib
- cMET Companion Diagnostic Assay - Brain Cancer
- cMET Companion Diagnostic Assay - Breast Cancer
- cMET Companion Diagnostic Assay - Kidney Cancer
- cMET Companion Diagnostic Assay - Lung Cancer
- Companion Diagnostic Test - B-cell Lymphoma
- Companion Diagnostic Test - Cancer
- COT Companion Diagnostic Assay - Melanoma
- CRAF Companion Diagnostic Assay - Melanoma
- CRLF2 Companion Diagnostic Assay - Acute Lymphocytic Leukemia
- D13S319/CEP12 Companion Diagnostic Assay - Chronic Lymphocytic Leukemia
- D5S23 Companion Diagnostic Assay - Cervical Cancer
- D5S23/D5S721 CEP 9 Companion Diagnostic Assay - Multiple Myeloma
- D5S721 Companion Diagnostic Assay - Acute Myeloid Leukemia
- D5S721 Companion Diagnostic Assay - Cervical Cancer
- D7S486 Companion Diagnostic Assay - Acute Myeloid Leukemia
- D7S486 Companion Diagnostic Assay - Myelodysplastic Syndrome
- D7S552 Companion Diagnostic Assay - Acute Myeloid Leukemia
- DCC Companion Diagnostic Assay - Colorectal Cancer
- DDR2 Companion Diagnostic Assay - Lung Cancer
- DEK/NUP214 Companion Diagnostic Assay - Acute Myeloid Leukemia
- del(13q) Companion Diagnostic Assay - Myelodysplastic Syndrome
- del(17p) Companion Diagnostic Assay - Chronic Lymphocytic Leukemia
- del(17p) Companion Diagnostic Assay - Multiple Myeloma
- del(5q) Companion Diagnostic Assay - Myelodysplastic Syndrome
- del(7q) Companion Diagnostic Assay - Myelodysplastic Syndrome
- del(9q) Companion Diagnostic Assay - Myelodysplastic Syndrome
- DOT1L Companion Diagnostic Test
- DPP4 Based Companion Diagnostic Assay - Asthma
- E2A/PBX1 (TCF/PBX1) Companion Diagnostic Assay - Acute Lymphocytic Leukemia
- EGFR Companion Diagnostic Assay - Brain Cancer
- EGFR Companion Diagnostic Assay - Glioblastoma
- EGFR Companion Diagnostic Assay - Lung Cancer
- EGFRvIII Companion Diagnostic Assay - Glioblastoma
- EGFRvIII Companion Diagnostic Assay - Lung Cancer
- EGR1/D5S23 Companion Diagnostic Assay - Acute Myeloid Leukemia
- EGR1/D5S23 Companion Diagnostic Assay - Myelodysplastic Syndrome
- EML4 Companion Diagnostic Assay - Lung Cancer
- ERBB3 Companion Diagnostic Assay - Bladder Cancer
- ERG Companion Diagnostic Assay - Prostate Cancer
- ETV Companion Diagnostic Assay - Sarcoma
- ETV1 Companion Diagnostic Assay - Prostate Cancer
- FGFR1 Companion Diagnostic Assay - Breast Cancer
- FGFR1 Companion Diagnostic Assay - Lung Cancer
- FGFR2 Companion Diagnostic Assay - Breast Cancer
- FGFR2 Companion Diagnostic Assay - Gastric Cancer
- FGFR2 Companion Diagnostic Assay - Lung Cancer
- FGFR3 Companion Diagnostic Assay - Bladder Cancer
- FGFR3-TACC3 Companion Diagnostic Assay - Bladder Cancer
- FGFR3-TACC3 Companion Diagnostic Assay - Lung Cancer
- GNA11 Companion Diagnostic Assay - Melanoma
- GNAQ Companion Diagnostic Assay - Melanoma
- H3F3A Companion Diagnostic Assay - Glioblastoma
- HER2 Companion Diagnostic Assay - Bladder Cancer
- HER2 Companion Diagnostic Assay - Breast Cancer
- HER2 Companion Diagnostic Assay - Gastric Cancer
- HER2 Companion Diagnostic Assay - Lung Cancer
- HER3 Companion Diagnostic Assay - Lung Cancer
- Heregulin Companion Diagnostic Assay - Lung Cancer
- HIF-1alpha Companion Diagnostic Assay - Renal Cancer
- HOX11L2/TLX3 Companion Diagnostic Assay - Acute Lymphocytic Leukemia
- Hyperdiploidy Companion Diagnostic Assay - Multiple Myeloma
- i(17q) Companion Diagnostic Assay - Myelodysplastic Syndrome
- iAMP21 Companion Diagnostic Assay - Acute Lymphoblastic Leukamia
- IDH1 Companion Diagnostic Assay - Biliary Cancer
- IDH1 Companion Diagnostic Assay - Glioblastoma
- IDH1 Companion Diagnostic Assay - Sarcoma
- IDH2 Companion Diagnostic Assay - Glioblastoma
- IDH2 Companion Diagnostic Assay - Sarcoma
- idic(X)(q13) Companion Diagnostic Assay - Myelodysplastic Syndrome
- IGF1R Companion Diagnostic Assay - Breast Cancer
- IGF1R Companion Diagnostic Assay - Colorectal Cancer
- IGF1R Companion Diagnostic Assay - Lung Cancer
- IGF1R Companion Diagnostic Assay - Melanoma
- IGF1R Companion Diagnostic Assay - Multiple Myeloma
- IGF1R Companion Diagnostic Assay - Prostate Cancer
- IGFR-1 Companion Diagnostic Assay - Breast Cancer
- IGFR-1 Companion Diagnostic Assay - Prostate Cancer
- IGFR1 Companion Diagnostic Assay - Solid Tumor
- IGH/CCND3 Companion Diagnostic Assay - Multiple Myeloma
- IGH/MAFB Companion Diagnostic Assay - Multiple Myeloma
- IKZF1 Companion Diagnostic Assay - Acute Lymphocytic Leukemia
- inv(17q) Companion Diagnostic Assay - Myelodysplastic Syndrome
- inv(3) Companion Diagnostic Assay - Myelodysplastic Syndrome
- inv(3)(3q21q26.2) Companion Diagnostic Assay - Myelodysplastic Syndrome
- JAK2 Companion Diagnostic Assay - Breast Cancer
- KEAP1 Companion Diagnostic Assay - Lung Cancer
- KIF5B Companion Diagnostic Assay - Lung Cancer
- KIT Companion Diagnostic Assay - Glioblastoma
- KRAS Companion Diagnostic Assay - Colorectal Cancer
- KRAS Companion Diagnostic Assay - Lung Cancer
- KRAS Companion Diagnostic Assay - Melanoma
- KRAS Companion Diagnostic Assay - Ovarian Cancer
- KRAS Companion Diagnostic Assay - Solid Tumors
- LKB1 Companion Diagnostic Assay - Lung Cancer
- MAGEA3 Companion Diagnostic Assay - Melanoma
- MAGEA3 Companion Diagnostic Assay - NSCLC
- MAP3K1 Companion Diagnostic Assay - Breast Cancer
- MCL1 Companion Diagnostic Assay - Biliary Cancer
- MCL1 Companion Diagnostic Assay - Leukemia
- MDM2/CEP12 Companion Diagnostic Assay - Sarcomas
- MEK Companion Diagnostic Assay - Melanoma
- MEK1 Companion Diagnostic Assay - Lung Cancer
- MET Companion Diagnostic Assay - Colorectal Cancer
- MET Companion Diagnostic Assay - Gastric Cancer
- MET Companion Diagnostic Assay - Lung Cancer
- MET Companion Diagnostic Assay - Ovarian Cancer
- Methotrexate Chemiluminescent Assay
- MGMT Companion Diagnostic Assay - Glioblastoma
- MLL Companion Diagnostic Assay - Leukemia
- MUC1 Companion Diagnostic Assay - Ovarian Cancer
- MYB Companion Diagnostic Assay - Melanoma
- MYC Companion Diagnostic Assay - Multiple Myeloma
- MYC Companion Diagnostic Assay - Prostate Cancer
- MYC t(8;14) Companion Diagnostic Assay - Acute Lymphocytic Leukemia
- MYCN Companion Diagnostic Assay - Prostate Cancer
- MYD88 Companion Diagnostic Assay - Lymphoma
- MYF11/CBFB inv (16)/t(16;16) Companion Diagnostic Assay - Acute Myeloid Leukemia
- MYST3/CREBBP Companion Diagnostic Assay - Acute Myeloid Leukemia
- Neuron-Specific Enolase (NSE) Assay
- Next Generation Blood Screening System
- NF1 Companion Diagnostic Assay - Lung Cancer
- NF1 Companion Diagnostic Assay - Melanoma
- NFE2L2 Companion Diagnostic Assay - Lung Cancer
- NKX3.1 Companion Diagnostic Assay - Prostate Cancer
- NPM1 Companion Diagnostic Assay - Acute Myeloid Leukemia
- NRAS Companion Diagnostic Assay - Colorectal Cancer
- NRAS Companion Diagnostic Assay - Lung Cancer
- NRAS Companion Diagnostic Assay - Melanoma
- NTRK1/2/3 Companion Diagnostic Assay - Colorectal Cancer
- NTRK1/2/3 Companion Diagnostic Assay - Lung Cancer
- NUP98 Companion Diagnostic Assay - Acute Myeloid Leukemia
- NUP98/RAP1GDS1 Companion Diagnostic Assay - Acute Lymphocytic Leukemia
- P53 Companion Diagnostic Assay - Brain Cancer
- p53 Companion Diagnostic Assay - Sarcoma
- PD-1/PD-L1 Companion Diagnostic Assay - Breast Cancer
- PD-L1 Companion Diagnostic Assay - Lung Cancer
- PD-L2 Companion Diagnostic Assay - Lung Cancer
- PDGFRA Companion Diagnostic Assay - Gastric Cancer
- PDGFRA Companion Diagnostic Assay - Glioblastoma
- PDGFRB Companion Diagnostic Assay - Acute Lymphocytic Leukemia
- PDGFRB Companion Diagnostic Assay - Melanoma
- PDGFRB Companion Diagnostic Assay - Myelodysplastic Syndrome
- Periostin Based Companion Diagnostic Assay - Asthma
- PICALM Companion Diagnostic Assay - Alzheimer’s Disease
- PIK3CA Companion Diagnostic Assay - Bladder Cancer
- PIK3CA Companion Diagnostic Assay - Brain Cancer
- PIK3CA Companion Diagnostic Assay - Breast Cancer
- PIK3CA Companion Diagnostic Assay - Colorectal Cancer
- PIK3CA Companion Diagnostic Assay - Kidney Cancer
- PIK3CA Companion Diagnostic Assay - Lung Cancer
- PIK3CA Companion Diagnostic Assay - Ovarian Cancer
- PIK3R1 Companion Diagnostic Assay - Glioblastoma
- PLEX-ID - Orthopedic Infection Rapid Assay
- PML/RARA Companion Diagnostic Assay - Myelodysplastic Syndrome
- Point-Of-Care Test - Hepatitis C Virus RNA Detection
- PRAME Antigen Lung Cancer Assay
- PTEN Companion Diagnostic Assay - Breast Cancer
- PTEN Companion Diagnostic Assay - Colorectal Cancer
- PTEN Companion Diagnostic Assay - Glioblastoma
- PTEN Companion Diagnostic Assay - Lung Cancer
- PTEN Companion Diagnostic Assay - Melanoma
- PTEN Companion Diagnostic Assay - Ovarian Cancer
- PTEN Companion Diagnostic Assay - Prostate Cancer
- PTEN Companion Diagnostic Assay - Renal Cancer
- RET Companion Diagnostic Assay - Lung Cancer
- ROS1 Companion Diagnostic Assay - Lung Cancer
- RPN11/MECOM inv(3) or t(3;3) Companion Diagnostic Assay - Acute Myeloid Leukemia
- RREB1 Companion Diagnostic Assay - Melanoma
- SARS-CoV-2 IgG II Quant Test
- Serology Test - Zika Virus
- SMAD4 Companion Diagnostic Assay - Colorectal Cancer
- t(15;17) Companion Diagnostic Assay - Myelodysplastic Syndrome
- t(17p) Companion Diagnostic Assay - Myelodysplastic Syndrome
- t(2;8) Companion Diagnostic Assay - Acute Lymphocytic Leukemia
- t(3;v) Companion Diagnostic Assay - Lymphoma
- t(8;21) Companion Diagnostic Assay - Myelodysplastic Syndrome
- t(8;22) Companion Diagnostic Assay - Acute Lymphocytic Leukemia
- TAL1/STIL Companion Diagnostic Assay - Acute Lymphocytic Leukamia
- TCR-B Companion Diagnostic Assay - Lymphoma
- TERC Companion Diagnostic Assay - Cervical Cancer
- TERT Companion Diagnostic Assay - Acute Myeloid Leukemia
- TERT Companion Diagnostic Assay - Breast Cancer
- TERT Companion Diagnostic Assay - Melanoma
- TLX3/BCL11B Companion Diagnostic Assay - Acute Lymphocytic Leukamia
- TOP2A Companion Diagnostic Assay - Breast Cancer
- TP53 Companion Diagnostic Assay - Breast Cancer
- TP53 Companion Diagnostic Assay - Leukemia
- TP53 Companion Diagnostic Assay - Melanoma
- TP53 Companion Diagnostic Assay - Multiple Myeloma
- TP53/ATM Companion Diagnostic Assay - Chronic Lymphocytic Leukemia
- TSC1 Companion Diagnostic Assay - Bladder Cancer
- Whole Blood Test - TBI
- Zinc Assay
- ZNF217 Companion Diagnostic Assay - Breast Cancer
- Abbott Diagnostics - Key Competitors
- Abbott Diagnostics - Key Employees
- Abbott Diagnostics - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Abbott Diagnostics, Recent Developments
- Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Table 1: Abbott Diagnostics Pipeline Products and Ongoing Clinical Trials Overview
- Table 2: Abbott Diagnostics Pipeline Products by Equipment Type
- Table 3: Abbott Diagnostics Pipeline Products by Indication
- Table 4: Abbott Diagnostics, Key Facts
- Table 5: Abbott Diagnostics, Major Products and Services
- Table 6: Abbott Diagnostics Number of Pipeline Products by Development Stage
- Table 7: Abbott Diagnostics Pipeline Products Summary by Development Stage
- Table 8: Abbott Diagnostics Ongoing Clinical Trials by Trial Status
- Table 9: Abbott Diagnostics Ongoing Clinical Trials Summary
- Table 10: q14.3 Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Status
- Table 11: q14.3 Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Description
- Table 12: ACTN4 Companion Diagnostic Assay - Lung Cancer - Product Status
- Table 13: ACTN4 Companion Diagnostic Assay - Lung Cancer - Product Description
- Table 14: AKT Companion Diagnostic Assay - Breast Cancer - Product Status
- Table 15: AKT Companion Diagnostic Assay - Breast Cancer - Product Description
- Table 16: AKT Companion Diagnostic Assay - Colorectal Cancer - Product Status
- Table 17: AKT Companion Diagnostic Assay - Colorectal Cancer - Product Description
- Table 18: AKT Companion Diagnostic Assay - Renal Cancer - Product Status
- Table 19: AKT Companion Diagnostic Assay - Renal Cancer - Product Description
- Table 20: Alinity i AdviseDx SARS-CoV-2 IgM Assay - Product Status
- Table 21: Alinity i AdviseDx SARS-CoV-2 IgM Assay - Product Description
- Table 22: Alinity i Assay - TBI - Product Status
- Table 23: Alinity i Assay - TBI - Product Description
- Table 24: ALK Companion Diagnostic Assay - Colorectal Cancer - Product Status
- Table 25: ALK Companion Diagnostic Assay - Colorectal Cancer - Product Description
- Table 26: ALK Companion Diagnostic Assay - Lung Cancer - Product Status
- Table 27: ALK Companion Diagnostic Assay - Lung Cancer - Product Description
- Table 28: AR Companion Diagnostic Assay - Breast Cancer - Product Status
- Table 29: AR Companion Diagnostic Assay - Breast Cancer - Product Description
- Table 30: AR Companion Diagnostic Assay - Prostate Cancer - Product Status
- Table 31: AR Companion Diagnostic Assay - Prostate Cancer - Product Description
- Table 32: Architect AdviseDx SARS-Cov-2 IgM Assay - Product Status
- Table 33: Architect AdviseDx SARS-Cov-2 IgM Assay - Product Description
- Table 34: Architect Assay - TBI - Product Status
- Table 35: Architect Assay - TBI - Product Description
- Table 36: ARCHITECT c16000 System - Ca 72.2 Assay - Product Status
- Table 37: ARCHITECT c16000 System - Ca 72.2 Assay - Product Description
- Table 38: ARCHITECT c4000 System - Ca 72.2 Assay - Product Status
- Table 39: ARCHITECT c4000 System - Ca 72.2 Assay - Product Description
- Table 40: ARCHITECT c4000 System - High Sensitive Troponin-I Assay - Product Status
- Table 41: ARCHITECT c4000 System - High Sensitive Troponin-I Assay - Product Description
- Table 42: ARCHITECT c4000 System - Kappa And Lamda Freelite Chains Assay - Product Status
- Table 43: ARCHITECT c4000 System - Kappa And Lamda Freelite Chains Assay - Product Description
- Table 44: ARCHITECT c4000 System - TRAb Assay - Product Status
- Table 45: ARCHITECT c4000 System - TRAb Assay - Product Description
- Table 46: ARCHITECT c8000 Integrated System - Galectin-3 Assay - Product Status
- Table 47: ARCHITECT c8000 Integrated System - Galectin-3 Assay - Product Description
- Table 48: ARCHITECT c8000 System - Ca 72.2 Assay - Product Status
- Table 49: ARCHITECT c8000 System - Ca 72.2 Assay - Product Description
- Table 50: ARCHITECT c8000 System - High Sensitive Troponin-I Assay - Product Status
- Table 51: ARCHITECT c8000 System - High Sensitive Troponin-I Assay - Product Description
- Table 52: ARCHITECT c8000 System - High Sensitive Troponin-I Assay - Australian New Zealand Acute Chest Pain (ANZACP) Registry: A Registry of the Investigation, Management and Outcomes of Patients Presenting to Two Australasian Hospitals with Chest Pain of Possible Cardiac Origin
- Table 53: ARCHITECT c8000 System - Kappa And Lamda Freelite Chains Assay - Product Status
- Table 54: ARCHITECT c8000 System - Kappa And Lamda Freelite Chains Assay - Product Description
- Table 55: ARCHITECT c8000 System - TRAb Assay - Product Status
- Table 56: ARCHITECT c8000 System - TRAb Assay - Product Description
- Table 57: ARCHITECT ci16200 Integrated System - Ca 72.2 Assay - Product Status
- Table 58: ARCHITECT ci16200 Integrated System - Ca 72.2 Assay - Product Description
- Table 59: ARCHITECT ci16200 Integrated System - Kappa And Lamda Freelite Chains Assay - Product Status
- Table 60: ARCHITECT ci16200 Integrated System - Kappa And Lamda Freelite Chains Assay - Product Description
- Table 61: ARCHITECT ci16200 Integrated System - NT Pro BNP Assay - Product Status
- Table 62: ARCHITECT ci16200 Integrated System - NT Pro BNP Assay - Product Description
- Table 63: ARCHITECT ci16200 Integrated System - TRAb Assay - Product Status
- Table 64: ARCHITECT ci16200 Integrated System - TRAb Assay - Product Description
- Table 65: ARCHITECT ci4100 Integrated System - NT Pro BNP Assay - Product Status
- Table 66: ARCHITECT ci4100 Integrated System - NT Pro BNP Assay - Product Description
- Table 67: ARCHITECT ci4100 Integrated System - TRAb Assay - Product Status
- Table 68: ARCHITECT ci4100 Integrated System - TRAb Assay - Product Description
- Table 69: ARCHITECT ci8200 Integrated System - Ca 72.2 Assay - Product Status
- Table 70: ARCHITECT ci8200 Integrated System - Ca 72.2 Assay - Product Description
- Table 71: ARCHITECT ci8200 Integrated System - Kappa And Lamda Freelite Chains Assay - Product Status
- Table 72: ARCHITECT ci8200 Integrated System - Kappa And Lamda Freelite Chains Assay - Product Description
- Table 73: ARCHITECT ci8200 Integrated System - TRAb Assay - Product Status
- Table 74: ARCHITECT ci8200 Integrated System - TRAb Assay - Product Description
- Table 75: ARCHITECT i1000SR - NT Pro BNP Assay - Product Status
- Table 76: ARCHITECT i1000SR - NT Pro BNP Assay - Product Description
- Table 77: ARCHITECT i2000SR Integrated System - NT Pro BNP Assay - Product Status
- Table 78: ARCHITECT i2000SR Integrated System - NT Pro BNP Assay - Product Description
- Table 79: ATM 11q22.3 Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Status
- Table 80: ATM 11q22.3 Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Description
- Table 81: AURKA Companion Diagnostic Assay - Bladder Cancer - Product Status
- Table 82: AURKA Companion Diagnostic Assay - Bladder Cancer - Product Description
- Table 83: AURKA Companion Diagnostic Assay - Prostate Cancer - Product Status
- Table 84: AURKA Companion Diagnostic Assay - Prostate Cancer - Product Description
- Table 85: AXL Companion Diagnostic Assay - Lung Cancer - Product Status
- Table 86: AXL Companion Diagnostic Assay - Lung Cancer - Product Description
- Table 87: BCL2 Companion Diagnostic Assay - Leukemia - Product Status
- Table 88: BCL2 Companion Diagnostic Assay - Leukemia - Product Description
- Table 89: BCL2 Companion Diagnostic Assay - Lymphoma - Product Status
- Table 90: BCL2 Companion Diagnostic Assay - Lymphoma - Product Description
- Table 91: BCL6 Companion Diagnostic Assay - Lymphoma - Product Status
- Table 92: BCL6 Companion Diagnostic Assay - Lymphoma - Product Description
- Table 93: BCR/ABL Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Status
- Table 94: BCR/ABL Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Description
- Table 95: BCR/ABL Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Status
- Table 96: BCR/ABL Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Description
- Table 97: Biomarker-Based Molecular Diagnostic Test - Prostate Cancer - Product Status
- Table 98: Biomarker-Based Molecular Diagnostic Test - Prostate Cancer - Product Description
- Table 99: BRAF Companion Diagnostic Assay - Colorectal Cancer - Product Status
- Table 100: BRAF Companion Diagnostic Assay - Colorectal Cancer - Product Description
- Table 101: BRAF Companion Diagnostic Assay - Gastric Cancer - Product Status
- Table 102: BRAF Companion Diagnostic Assay - Gastric Cancer - Product Description
- Table 103: BRAF Companion Diagnostic Assay - Glioblastoma - Product Status
- Table 104: BRAF Companion Diagnostic Assay - Glioblastoma - Product Description
- Table 105: BRAF Companion Diagnostic Assay - Lung Cancer - Product Status
- Table 106: BRAF Companion Diagnostic Assay - Lung Cancer - Product Description
- Table 107: BRAF Companion Diagnostic Assay - Melanoma - Product Status
- Table 108: BRAF Companion Diagnostic Assay - Melanoma - Product Description
- Table 109: BRAF Companion Diagnostic Assay - Ovarian Cancer - Product Status
- Table 110: BRAF Companion Diagnostic Assay - Ovarian Cancer - Product Description
- Table 111: BRCA1 Companion Diagnostic Assay - Ovarian Cancer - Product Status
- Table 112: BRCA1 Companion Diagnostic Assay - Ovarian Cancer - Product Description
- Table 113: BRCA2 Companion Diagnostic Assay - Ovarian Cancer - Product Status
- Table 114: BRCA2 Companion Diagnostic Assay - Ovarian Cancer - Product Description
- Table 115: c-MYC 8q24 Companion Diagnostic Assay - Multiple Myeloma - Product Status
- Table 116: c-MYC 8q24 Companion Diagnostic Assay - Multiple Myeloma - Product Description
- Table 117: CBFB Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Status
- Table 118: CBFB Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Description
- Table 119: CCND1 Companion Diagnostic Assay - Breast Cancer - Product Status
- Table 120: CCND1 Companion Diagnostic Assay - Breast Cancer - Product Description
- Table 121: CCND1 Companion Diagnostic Assay - Lymphoma - Product Status
- Table 122: CCND1 Companion Diagnostic Assay - Lymphoma - Product Description
- Table 123: CCND1 Companion Diagnostic Assay - Melanoma - Product Status
- Table 124: CCND1 Companion Diagnostic Assay - Melanoma - Product Description
- Table 125: CDK6 Companion Diagnostic Assay - Leukemia - Product Status
- Table 126: CDK6 Companion Diagnostic Assay - Leukemia - Product Description
- Table 127: CDKN2C Companion Diagnostic Assay - Multiple Myeloma - Product Status
- Table 128: CDKN2C Companion Diagnostic Assay - Multiple Myeloma - Product Description
- Table 129: CEBPE Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Status
- Table 130: CEBPE Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Description
- Table 131: CEP 9 Companion Diagnostic Assay - Multiple Myeloma - Product Status
- Table 132: CEP 9 Companion Diagnostic Assay - Multiple Myeloma - Product Description
- Table 133: Chromosome 12 Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Status
- Table 134: Chromosome 12 Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Description
- Table 135: Chromosome 17 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Status
- Table 136: Chromosome 17 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Description
- Table 137: Chromosome 3 Companion Diagnostic Assay - Cervical Cancer - Product Status
- Table 138: Chromosome 3 Companion Diagnostic Assay - Cervical Cancer - Product Description
- Table 139: Chromosome 4 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Status
- Table 140: Chromosome 4 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Description
- Table 141: Chromosome 7 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Status
- Table 142: Chromosome 7 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Description
- Table 143: Chromosome 7 Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Status
- Table 144: Chromosome 7 Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Description
- Table 145: Chromosome 8 Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Status
- Table 146: Chromosome 8 Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Description
- Table 147: Chromosome X Companion Diagnostic Assay - Cervical Cancer - Product Status
- Table 148: Chromosome X Companion Diagnostic Assay - Cervical Cancer - Product Description
- Table 149: cKIT Companion Diagnostic Assay - Gastric Cancer - Product Status
- Table 150: cKIT Companion Diagnostic Assay - Gastric Cancer - Product Description
- Table 151: cKIT Companion Diagnostic Assay - Melanoma - Product Status
- Table 152: cKIT Companion Diagnostic Assay - Melanoma - Product Description
- Table 153: CKS1B Companion Diagnostic Assay - Breast Cancer - Product Status
- Table 154: CKS1B Companion Diagnostic Assay - Breast Cancer - Product Description
- Table 155: CKS1B Companion Diagnostic Assay - Multiple Myeloma - Product Status
- Table 156: CKS1B Companion Diagnostic Assay - Multiple Myeloma - Product Description
- Table 157: CLL FISH Probe Kit - Ibrutinib - Product Status
- Table 158: CLL FISH Probe Kit - Ibrutinib - Product Description
- Table 159: cMET Companion Diagnostic Assay - Brain Cancer - Product Status
- Table 160: cMET Companion Diagnostic Assay - Brain Cancer - Product Description
- Table 161: cMET Companion Diagnostic Assay - Breast Cancer - Product Status
- Table 162: cMET Companion Diagnostic Assay - Breast Cancer - Product Description
- Table 163: cMET Companion Diagnostic Assay - Kidney Cancer - Product Status
- Table 164: cMET Companion Diagnostic Assay - Kidney Cancer - Product Description
- Table 165: cMET Companion Diagnostic Assay - Lung Cancer - Product Status
- Table 166: cMET Companion Diagnostic Assay - Lung Cancer - Product Description
- Table 167: Companion Diagnostic Test - B-cell Lymphoma - Product Status
- Table 168: Companion Diagnostic Test - B-cell Lymphoma - Product Description
- Table 169: Companion Diagnostic Test - Cancer - Product Status
- Table 170: Companion Diagnostic Test - Cancer - Product Description
- Table 171: COT Companion Diagnostic Assay - Melanoma - Product Status
- Table 172: COT Companion Diagnostic Assay - Melanoma - Product Description
- Table 173: CRAF Companion Diagnostic Assay - Melanoma - Product Status
- Table 174: CRAF Companion Diagnostic Assay - Melanoma - Product Description
- Table 175: CRLF2 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Status
- Table 176: CRLF2 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Description
- Table 177: D13S319/CEP12 Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Status
- Table 178: D13S319/CEP12 Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Description
- Table 179: D5S23 Companion Diagnostic Assay - Cervical Cancer - Product Status
- Table 180: D5S23 Companion Diagnostic Assay - Cervical Cancer - Product Description
- Table 181: D5S23/D5S721
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.